Every finding on record at Amedisys Tennessee, L.L.C.

A Health Emergency Preparedness survey was conducted on 1/6/2025 through 1/8/2025 with the recertification survey. The facility meets all requirements reviewed for Emergency Preparedness.

A recertification survey was conducted along with a Health Emergency Preparedness survey conducted on 1/6/2025 through 1/8/2025. An entrance conference was held with the Director of Operations and the Office Manager. An exit conference was held on 1/8/2025 with the Area Vice President of Operations, Clinical Area Vice President, Director of Operations at Covington, Director of Operations Park/Memphis, Clinical Managers, and Office Manager.

Patient medication schedule/instructions CFR(s): 484.60(e)(2) Patient medication schedule/instructions, including: medication name, dosage and frequency and which medications will be administered by HHA personnel and personnel acting on behalf of the HHA. This ELEMENT is not met as evidenced by: Based on policy review, medical record review, observation and interview, the facility failed to ensure an updated and accurate medication profile for 4 of 7 (Patient #1, 2, 4 and 6) sampled patients with home visits. The findings included: 1. Review of the facility's "Drug Regimen Review (Home Health Only)" policy with a review date of 12/9/2024 revealed, "…Purpose: To identify appropriateness, inconsistencies, and/or significant drug interactions in the patient’s current medication regimen, as well as ensure the comprehensive list of medications are updated any time there is a medication change including dose changes, new medications, and any medications discontinued.” 2. Medical record review for Patient #1 revealed a Plan of Care (POC) dated 1/7/2025 through 3/7/2025 with a primary diagnosis of End Stage Renal Disease, Dependence on Renal Dialysis. Review of the Home Health Certification and Plan of Care dated 1/7/2025 through 3/7/2025, revealed “…Cefdinir (treats infection) 300 mg (milligrams)...oral...every other day..." Observations in Patient #1’s home 1/7/2025 at 1:32 PM, revealed Patient #1 was taking Lantus (insulin) 45 units subcutaneous at bedtime, and Lispro Insulin 5 units subcutaneous three times a day. These medications were not listed on the Medication Profile. Further review revealed Cefdinir 300 mg (milligrams) one every 48 hours, two tablets, filled on 11/5/2024 was listed on the Medication Profile. In an interview during the home visit, Patient #1’s verified she was taking both Lantus and Lispro insulin and had been on them for a long time. Patient #1 confirmed she finished Cefdinir in November and was no longer taking. In an interview with Physical Therapist (PT) #1 on 1/7/2025 during the home visit, PT #1 verified medications had not been updated. 3. Medical record review for Patient #2 revealed a POC dated 12/1/2024 through 1/29/2025 with a primary diagnosis of Paraplegia, Stage 3 Pressure Ulcer to the Sacral Region. Review of the Home Health Certification and Plan of Care dated 12/1/2024 through 1/9/2025, revealed “…Baclofen (treats muscle spasms) 20 mg...oral...3 times daily...; Gabapentin 300 mg...oral...two times a daily..." Observations in Patient #2’s home on 1/7/2025 at 12:27 PM, revealed Gabapentin (treats pain) 300 mg, 2 times daily was listed on the Medication Profile, the pill bottle of Gabapentin revealed 400 mg 1 tablet 4 times a day. Further review revealed Cephalexin (treats infection) 250 mg, one capsule daily filled on 12/9/2024 for 90 capsules was not listed on the Medication Profile. In an interview during the home visit, Patient #2’s verified she was taking the Gabapentin 400 mg, one four times a day and Cephalexin 250 mg one a day. In an interview with Registered Nurse (RN) #1 on 1/7/2025 during the home visit, RN #1 verified medications had not been updated to reflect current medications, and stated he would update the medication. 4. Medical record review for Patient #4 revealed a Plan of Care (POC) dated 12/26/2024 through 2/23/2025 with a primary diagnosis Hemiplegia, Peripheral Vascular Disease, Raynaud’s Syndrome, Hypertension, Chronic Obstructive Pulmonary Disease, and Anxiety. Review of the Home Health Certification and Plan of Care dated 12/26/2024 through 2/23/2025, revealed “…Aspirin [analgesic] 81 mg …oral…daily; Atorvastatin [treats high cholesterol]40 mg oral…bedtime; Cetirizine [treats Rhinitis] 10 mg…oral…daily; Clopidogrel [anticoagulant] 75 mg…oral…daily; Gabapentin [treats neurological pain] 300 mg…oral…3 times daily; Linzess [treats constipation] 145 mcg [micrograms]…oral…daily; Metoprolol [antihypertensive]…25 mg…oral…daily; Ondansetron [anti-nausea] 4 mg…oral…every 6 hours/prn [as needed]; Oxybutynin [treats bladder spasms] 5 mg…oral…two times daily; Tizanidine [treats muscle spasms] 2 mg…oral…daily; and Valsartan [antihypertensive] 160 mg…oral…daily…” Review of Patient’s home medications revealed Atorvastatin 20 mg dated 12/5/2024 and Gabapentin 300 mg twice daily. In an interview during the home visit, Patient #4’s verified she was not taking Aspirin, Cetirizine, Clopidogrel, Linzess, Metoprolol, Ondansetron, Oxybutynin, Tizanidine, and Valsartan. In an interview during the home visit, Clinical Manager #1 confirmed Patient #4’s medication needed reconciled, and physician needed to be contacted. 5. Medical record review for Patient #6 revealed a POC dated 12/14/2024 through 2/11/2025 with a primary diagnosis of Pulmonary Embolism, Epilepsy, and Depression. Review of the Home Health Certification and Plan of Care dated 12/14/2024 through 2/11/2025, revealed “…Diclofenac Sodium 75 mg...oral...twice daily...; Metoprolol Tartrate (used to treat chest pain)...oral...two times daily..." Observations in Patient #6’s home on 1/7/2025 at 3:20 PM revealed Diclofenac Sodium (used to treat pain) 75 mg tablet twice daily was listed on the Medication Profile and medication had been stopped 11/2024. Further review revealed Duloxetine (treats depression) 60 mg tablet one daily, was not listed on the Medication Profile. In an interview during the home visit, Patient #6’s verified she was not taking the Diclofenac since November 2024 and had been on Duloxetine for the past 19 to 20 years. In an interview with the Occupational Therapist #1 on 1/7/2025 during the home visit, OT #1 verified medications had not been updated to reflect current medications, and stated he would update the medication. In an interview on 1/8/2025 at 2:30 PM with the Area Vice President-Clinical confirmed staff are to review the medications and are updated the Medication Profile.